Hirvonen A - Search Results

1

XRCC1 and XPD genetic polymorphisms, smoking and breast cancer risk in a Finnish case-control study.

Metsola K, Kataja V, Sillanpää P, Siivola P, Heikinheimo L, Eskelinen M, Kosma VM, Uusitupa M, Hirvonen A. Metsola K, et al. Among authors: hirvonen a. Breast Cancer Res. 2005;7(6):R987-97. doi: 10.1186/bcr1333. Epub 2005 Oct 11. Breast Cancer Res. 2005. PMID: 16280050 Free PMC article.

2

Combined COMT and GST genotypes and hormone replacement therapy associated breast cancer risk.

Mitrunen K, Kataja V, Eskelinen M, Kosma VM, Kang D, Benhamou S, Vainio H, Uusitupa M, Hirvonen A. Mitrunen K, et al. Among authors: hirvonen a. Pharmacogenetics. 2002 Jan;12(1):67-72. doi: 10.1097/00008571-200201000-00009. Pharmacogenetics. 2002. PMID: 11773866

3

Vitamin D receptor gene polymorphism as an important modifier of positive family history related breast cancer risk.

Sillanpää P, Hirvonen A, Kataja V, Eskelinen M, Kosma VM, Uusitupa M, Vainio H, Mitrunen K. Sillanpää P, et al. Among authors: hirvonen a. Pharmacogenetics. 2004 Apr;14(4):239-45. doi: 10.1097/00008571-200404000-00003. Pharmacogenetics. 2004. PMID: 15083068

4

NAT2 slow acetylator genotype as an important modifier of breast cancer risk.

Sillanpää P, Hirvonen A, Kataja V, Eskelinen M, Kosma VM, Uusitupa M, Vainio H, Mitrunen K. Sillanpää P, et al. Among authors: hirvonen a. Int J Cancer. 2005 Apr 20;114(4):579-84. doi: 10.1002/ijc.20677. Int J Cancer. 2005. PMID: 15609332

5

Sulfotransferase 1A1 genotype as a potential modifier of breast cancer risk among premenopausal women.

Sillanpää P, Kataja V, Eskelinen M, Kosma VM, Uusitupa M, Vainio H, Mitrunen K, Hirvonen A. Sillanpää P, et al. Among authors: hirvonen a. Pharmacogenet Genomics. 2005 Oct;15(10):749-52. doi: 10.1097/01.fpc.0000172240.34923.46. Pharmacogenet Genomics. 2005. PMID: 16141802

6

CYP1A1 and CYP1B1 genetic polymorphisms, smoking and breast cancer risk in a Finnish Caucasian population.

Sillanpää P, Heikinheimo L, Kataja V, Eskelinen M, Kosma VM, Uusitupa M, Vainio H, Metsola K, Hirvonen A. Sillanpää P, et al. Among authors: hirvonen a. Breast Cancer Res Treat. 2007 Sep;104(3):287-97. doi: 10.1007/s10549-006-9414-6. Epub 2006 Oct 25. Breast Cancer Res Treat. 2007. PMID: 17063266

7

XRCC1 rs25487 polymorphism predicts the survival of patients after postoperative radiotherapy and adjuvant chemotherapy for breast cancer.

Tengström M, Mannermaa A, Kosma VM, Hirvonen A, Kataja V. Tengström M, et al. Among authors: hirvonen a. Anticancer Res. 2014 Jun;34(6):3031-7. Anticancer Res. 2014. PMID: 24922669

8

Steroid metabolism gene CYP17 polymorphism and the development of breast cancer.

Mitrunen K, Jourenkova N, Kataja V, Eskelinen M, Kosma VM, Benhamou S, Vainio H, Uusitupa M, Hirvonen A. Mitrunen K, et al. Among authors: hirvonen a. Cancer Epidemiol Biomarkers Prev. 2000 Dec;9(12):1343-8. Cancer Epidemiol Biomarkers Prev. 2000. PMID: 11142420

9

Glutathione S-transferase M1, M3, P1, and T1 genetic polymorphisms and susceptibility to breast cancer.

Mitrunen K, Jourenkova N, Kataja V, Eskelinen M, Kosma VM, Benhamou S, Vainio H, Uusitupa M, Hirvonen A. Mitrunen K, et al. Among authors: hirvonen a. Cancer Epidemiol Biomarkers Prev. 2001 Mar;10(3):229-36. Cancer Epidemiol Biomarkers Prev. 2001. PMID: 11303592

10

Association between manganese superoxide dismutase (MnSOD) gene polymorphism and breast cancer risk.

Mitrunen K, Sillanpää P, Kataja V, Eskelinen M, Kosma VM, Benhamou S, Uusitupa M, Hirvonen A. Mitrunen K, et al. Among authors: hirvonen a. Carcinogenesis. 2001 May;22(5):827-9. doi: 10.1093/carcin/22.5.827. Carcinogenesis. 2001. PMID: 11323405

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

220 results

Search Page

Filters